111 related articles for article (PubMed ID: 7641741)
1. Clinical implication of fos and jun expressions and protein kinase activity in endometrial cancers.
Fujimoto J; Hori M; Ichigo S; Morishita S; Tamaya T
Eur J Gynaecol Oncol; 1995; 16(2):138-46. PubMed ID: 7641741
[TBL] [Abstract][Full Text] [Related]
2. Estrogen induces expression of c-fos and c-jun via activation of protein kinase C in an endometrial cancer cell line and fibroblasts derived from human uterine endometrium.
Fujimoto J; Hori M; Ichigo S; Morishita S; Tamaya T
Gynecol Endocrinol; 1996 Apr; 10(2):109-18. PubMed ID: 8701784
[TBL] [Abstract][Full Text] [Related]
3. Estrogen induces the expression of c-fos and c-jun genes in fibroblasts derived from human uterine endometrium.
Fujimoto J; Ilori M; Ichigo S; Morishita S; Tamaya T
Exp Clin Endocrinol Diabetes; 1995; 103(6):378-85. PubMed ID: 8788311
[TBL] [Abstract][Full Text] [Related]
4. C-fos and c-jun expression in human endometrium and myometrium.
Salmi A; Rutanen FM
Mol Cell Endocrinol; 1996 Mar; 117(2):233-40. PubMed ID: 8737385
[TBL] [Abstract][Full Text] [Related]
5. The association between c-fos and c-jun expression and estrogen and progesterone receptors is lost in human endometrial cancer.
Salmi A; Carpén O; Rutanen E
Tumour Biol; 1999; 20(4):202-11. PubMed ID: 10393530
[TBL] [Abstract][Full Text] [Related]
6. Expression of fos and jun proto-oncogenes in benign versus malignant human uterine tissue.
Nephew KP; Choi CM; Polek TC; McBride R; Bigsby RM; Khan SA; Husseinzadeh N
Gynecol Oncol; 2000 Mar; 76(3):388-96. PubMed ID: 10684716
[TBL] [Abstract][Full Text] [Related]
7. Regulation of AP-1 expression and activity in antigen-stimulated mast cells: the role played by protein kinase C and the possible involvement of Fos interacting protein.
Lewin I; Nechushtan H; Ke Q; Razin E
Blood; 1993 Dec; 82(12):3745-51. PubMed ID: 8260711
[TBL] [Abstract][Full Text] [Related]
8. Preventive effects of isoflavones, genistein and daidzein, on estradiol-17beta-related endometrial carcinogenesis in mice.
Lian Z; Niwa K; Tagami K; Hashimoto M; Gao J; Yokoyama Y; Mori H; Tamaya T
Jpn J Cancer Res; 2001 Jul; 92(7):726-34. PubMed ID: 11473722
[TBL] [Abstract][Full Text] [Related]
9. Tissue differences in the expression of mRNAs of Ha-ras, c-myc, fos and jun in human uterine endometrium, myometrium and leiomyoma under the influence of estrogen/progesterone.
Fujimoto J; Hori M; Ichigo S; Nishigaki M; Tamaya T
Tumour Biol; 1994; 15(6):311-7. PubMed ID: 7997802
[TBL] [Abstract][Full Text] [Related]
10. Proto-oncogenes c-jun and c-fos are down-regulated in human endometrium during pregnancy: relationship to oestrogen receptor status.
Salmi A; Ammälä M; Rutanen EM
Mol Hum Reprod; 1996 Dec; 2(12):979-84. PubMed ID: 9237242
[TBL] [Abstract][Full Text] [Related]
11. Analysis of differential gene regulation in adequate versus inadequate secretory-phase endometrial complementary deoxyribonucleic acid populations from the rhesus monkey.
Okulicz WC; Ace CI; Longcope C; Tast J
Endocrinology; 1996 Nov; 137(11):4844-50. PubMed ID: 8895355
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase C activation and protooncogene expression in differentiation/retrodifferentiation of human U-937 leukemia cells.
Hass R; Pfannkuche HJ; Kharbanda S; Gunji H; Meyer G; Hartmann A; Hidaka H; Resch K; Kufe D; Goppelt-Strübe M
Cell Growth Differ; 1991 Nov; 2(11):541-8. PubMed ID: 1814434
[TBL] [Abstract][Full Text] [Related]
13. Value of glutathione S-transferase pi and the oncogene products c-Jun, c-Fos, c-H-Ras, and c-Myc as a prognostic indicator in endometrial carcinomas.
Yokoyama Y; Sagara M; Sato S; Saito Y
Gynecol Oncol; 1998 Mar; 68(3):280-7. PubMed ID: 9570981
[TBL] [Abstract][Full Text] [Related]
14. Expression of sex hormone-binding globulin mRNA in human endometrial cancers.
Misao R; Nakanishi Y; Ichigo S; Hori M; Fujimoto J; Tamaya T
J Steroid Biochem Mol Biol; 1995 Jun; 52(6):517-22. PubMed ID: 7779755
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of c-myc, c-jun and estrogen receptor in normal, hyperplastic and neoplastic endometrium.
Bircan S; Ensari A; Ozturk S; Erdogan N; Dundar I; Ortac F
Pathol Oncol Res; 2005; 11(1):32-9. PubMed ID: 15800680
[TBL] [Abstract][Full Text] [Related]
16. Expressions of vascular endothelial growth factor (VEGF) and its mRNA in uterine endometrial cancers.
Fujimoto J; Ichigo S; Hirose R; Sakaguchi H; Tamaya T
Cancer Lett; 1998 Dec; 134(1):15-22. PubMed ID: 10381125
[TBL] [Abstract][Full Text] [Related]
17. Evidence for enhanced expression of c-fos, c-jun, and the Ca(2+)-activated neutral protease in rat liver following carbon tetrachloride administration.
Zawaski K; Gruebele A; Kaplan D; Reddy S; Mortensen A; Novak RF
Biochem Biophys Res Commun; 1993 Dec; 197(2):585-90. PubMed ID: 8267594
[TBL] [Abstract][Full Text] [Related]
18. Overexpressions of c-fos/jun mRNA and their oncoproteins (Fos/Jun) in the mouse uterus treated with three natural estrogens.
Morishita S; Niwa K; Ichigo S; Hori M; Murase T; Fujimoto J; Tamaya T
Cancer Lett; 1995 Nov; 97(2):225-31. PubMed ID: 7497467
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of interleukin-3-dependent mast cell proliferation by suppression of c-jun expression.
Chaikin E; Hakeem I; Razin E
J Biol Chem; 1994 Mar; 269(11):8498-503. PubMed ID: 8132577
[TBL] [Abstract][Full Text] [Related]
20. Protein kinases C-beta and C-epsilon link the mast cell high-affinity receptor for IgE to the expression of c-fos and c-jun.
Razin E; Szallasi Z; Kazanietz MG; Blumberg PM; Rivera J
Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7722-6. PubMed ID: 8052650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
